ABMART Overview

Founded 2007
Status Private
Employees 150
Latest Deal Type Early Stage VC
Investors 1

ABMART General Information


Developer of monoclonal antibodies intended to be used for the drug discovery application. The company's monoclonal antibodies are used in high-throughput pharmaceutical targets and protein biomarker discovery, enabling the researchers to create new drugs using them in the field of biological and pharmaceutical industry.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Room 1-3, Building 1
  • Juke Biology Park, 333 Guiping Road
  • Shanghai, Xuhui District
  • China
+86 400 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ABMART Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Jan-2011 Completed Startup
1. Early Stage VC 01-Jan-2008 Completed Startup

ABMART Executive Team (2)

Name Title Board Seat Contact Info
Xun Meng Ph.D Chief Executive Officer & Founder
Changzheng Chen Co-Founder

ABMART Investors (1)

To view ABMART‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Northern Light Venture Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial